A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract.
Ponce DM, Alousi AM, Nakamura R, Slingerland J, Calafiore M, Sandhu KS, Barker JN, Devlin S, Shia J, Giralt S, Perales MA, Moore G, Fatmi S, Soto C, Gomes A, Giardina P, Marcello L, Yan X, Tang T, Dreyer K, Chen J, Daley WL, Peled JU, van den Brink MRM, Hanash AM.
Ponce DM, et al. Among authors: daley wl.
Blood. 2023 Mar 23;141(12):1389-1401. doi: 10.1182/blood.2021015111.
Blood. 2023.
PMID: 36399701
Free PMC article.
Clinical Trial.